Clinical Trial Update: BEYOND Pilot Study [Phase 2]

View source ↗

Summary

The BEYOND Pilot Study, a Phase 2 trial sponsored by Bayer, has completed in relapsing-remitting multiple sclerosis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Sclerosis
• Relapsing-remitting Multiple Sclerosis

Snippet

Sponsor: Bayer | Conditions: Multiple Sclerosis, Relapsing-Remitting | Phase 2 | Status: COMPLETED